Submissions for variant NM_001370658.1(BTD):c.197T>G (p.Met66Arg)

gnomAD frequency: 0.00001  dbSNP: rs587783002

Total submissions: 4

Submitter	RCV	SCV	Clinical significance	Condition	Last evaluated	Review status	Method	Comment
Labcorp Genetics (formerly Invitae), Labcorp	RCV000144056	SCV002263079	pathogenic	Biotinidase deficiency	2024-04-30	criteria provided, single submitter	clinical testing	This sequence change replaces methionine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 86 of the BTD protein (p.Met86Arg). This variant is present in population databases (rs587783002, gnomAD 0.0009%). This missense change has been observed in individual(s) with partial biotinidase deficiency (PMID: 24797656, 25144890, 26361991). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 156000). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt BTD protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic.
Women's Health and Genetics/Laboratory Corporation of America, LabCorp	RCV003323415	SCV004029301	uncertain significance	not specified	2023-07-18	criteria provided, single submitter	clinical testing	Variant summary: BTD c.197T>G (p.Met66Arg) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4e-06 in 251402 control chromosomes (gnomAD). c.197T>G has been reported in the literature in individuals affected with Partial Biotinidase Deficiency (examples: Li_2014, Jay_2015 and Gannavarapu_2015). These data indicate that the variant may be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 26361991, 25144890, 24797656). One submitter has cited clinical-significance assessments for this variant to ClinVar after 2014 and has classified the variant as likely pathogenic. Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic.
Baylor Genetics	RCV000144056	SCV004211450	likely pathogenic	Biotinidase deficiency	2023-07-03	criteria provided, single submitter	clinical testing
Molecular Genetics Diagnostic Laboratory, Detroit Medical Center University Laboratories	RCV000144056	SCV000189129	pathogenic	Biotinidase deficiency		no assertion criteria provided	clinical testing